Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity in brain tissue from people ...

A University of Kentucky researcher is leading a team in what the university calls a groundbreaking study. According to UK, the study identifies biological markers for schizophrenia, which could ...

UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...

Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue that holds neurons together, but glial cells can also be helpful in promoting ...

Scientists have found a new way to study serious mental health conditions by growing very small human brains in the lab. These tiny brains are about the size of a pea, but they may help doctors better ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to ...

How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to a press release. “This drug takes the first new approach to ...